US Pharma MarketingCMS grants Elevance Health a reprieve from Medicare Advantage sanctions
CMS grants Elevance Health a reprieve from Medicare Advantage sanctions is a pharma and life sciences industry update from Fierce Healthcare. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Elevance Health has earned a reprieve from potential federal sanctions on its Medicare Advantage plans.
Source: Fierce Healthcare